ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study
Ann Surg Oncol. 2023 Sep;30(9):5895-5896.
doi: 10.1245/s10434-023-13687-x.
Epub 2023 Jun 2.
1 Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
2 Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. masayuki.watanabe@jfcr.or.jp.
3 Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. masayuki.watanabe@jfcr.or.jp.
4 Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan.
5 Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.
6 Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
7 Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
8 Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
9 Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
10 Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.